In HR-positive tumors, while there was a higher infiltration of CD4+ T cells compared to CD8+ T cells in pure DCIS (p < 0.001), there was no difference in the amount of infiltration between the two TIL subsets in invasive carcinoma (p = 0.580). This evidence concerns the gene CD8A and ductal breast carcinoma in situ.